Doxazosin Mesylate
- Product NDC
- 43353-740
- 11-digit product format
- 433530740
- Labeler code
- 43353
- Product ID
- 43353-740_30c400c9-6ac0-44c8-ab03-f18c634c23cf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076161
- Marketing category
- ANDA
- Marketing start
- 2011-07-20
- Marketing end
- 0000-00-00
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-740 | DOXAZOSIN MESYLATE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | Legacy NDC | 20171128_6383536f-2013-462a-aba8-3c0d9659d76c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-740-60 | 43353074060 | 90 TABLET in 1 BOTTLE (43353-740-60) | 90 tablet | 2011-07-20 | 0000-00-00 | No | No | Current |